Nuheara: Receives ethics approval to begin clinical trials

Nuheara Receives ethics approval to begin clinical trials

  • Nuheara (NUH) has received ethics approval from the Australian Hearing Human Research Ethics Committee (AHHREC) to commence its medical device clinical trial
  • The company has been working to develop multi-functional, personalised, intelligent hearing devices that augment a person’s hearing
  • The company said this supports its planned expansion into clinically tested and regulatory approved medical devices
  • The company Co-founder, Managing Director and CEO Justin Miller said National Acoustics Laboratories has now commenced recruiting for company’s medical device clinical trial
  • Recruitment has already begun for the trial, which the company says supports its planned expansion into clinically tested and regulatory approved medical devices
Steve Sam
Steve Sam
Steve Sam is a financial reporter, analyst, and commentator with a strong focus on banking technology, digital payments, and the future of financial services.

You May Also Like

Brink’s Strengthens Position with $6.6B NCR Acquisition

Brink's expands its services through strategic acquisition of NCR's Atleos.Highlights: Brink's acquires NCR Atleos for $6.6 billion.The deal...

Barclays Strengthens Blockchain Payments Platform Discussions

Bank explores blockchain vendors for enhanced payment solutions.Highlights: Barclays explores blockchain technology for payments.Bank engages with various vendors...

Lloyds Tightens Bank Account Opening Process in Branches

The bank limits account openings amidst ongoing service updates.Highlights: Lloyds will restrict opening some bank accounts in branches.The...

Jack Dorsey’s Block to Lay Off 4,000 Employees as AI Era Advances

Significant workforce reduction reflects shifts in technology focus.Highlights: Block announces 4,000 layoffs amid evolving AI landscape.The decision comes...